DRD2 and Alzheimer disease: It is clear that cholinergic pathways may be important avenues to explore in the development of new treatments for psychotic symptoms in AD while avoiding the known deleterious consequences of a direct D2R blockade [130], but the further development of preclinical models of behavior and pathology that emerge from cholinergic deficits may be important corollaries to these efforts.